DGAP-News: Themis Beteiligungs-Aktiengesellschaft completes partial sale of existing shares in Dermapharm Holding SE
Retrieved on:
Wednesday, October 14, 2020
Themis Beteiligungs-Aktiengesellschaft, main shareholder in Dermapharm Holding SE, has successfully completed the announced placement of shares in Dermapharm Holding SE.
Key Points:
- Themis Beteiligungs-Aktiengesellschaft, main shareholder in Dermapharm Holding SE, has successfully completed the announced placement of shares in Dermapharm Holding SE.
- Themis Beteiligungs-Aktiengesellschaft has sold 5,384,000 shares in Dermapharm Holding SE, corresponding to 10.0% of the outstanding share capital.
- Themis Beteiligungs-Aktiengesellschaft will remain the major shareholder with c. 65.05% of the outstanding share capital in Dermapharm Holding SE.
- Aside from Themis Beteiligungs-Aktiengesellschaft's completed private placement of part of its shareholding in Dermapharm Holding SE, Themis Beteiligungs-Aktiengesellschaft does currently not intend to further decrease its position as a major shareholder in Dermapharm Holding SE.